HT
GSK icon

HAP Trading’s GSK GSK Stock Holding History

HAP Trading’s Portfolio GSK Stock Details GSK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q3 		– Sell
-199,520
Closed -$807K – 1859
2022
Q2 		$807K Buy
199,520
+131,840
+195% +$7.28M 0.04% 339
2022
Q1 		$89K Buy
67,680
+29,680
+78% +$1.61M ﹤0.01% 1090
2021
Q4 		$43K Buy
38,000
+3,280
+9% +$171K ﹤0.01% 1542
2021
Q3 		$12K Sell
34,720
-16,880
-33% -$848K ﹤0.01% 1957
2021
Q2 		$131K Buy
51,600
+30,320
+142% +$1.46M ﹤0.01% 1131
2021
Q1 		$7K Buy
21,280
+800
+4% +$36.3K ﹤0.01% 1696
2020
Q4 		$11K Buy
20,480
+6,240
+44% +$287K ﹤0.01% 1880
2020
Q3 		$4K Sell
14,240
-14,640
-51% -$734K ﹤0.01% 1462
2020
Q2 		$32K Buy
28,880
+18,240
+171% +$936K ﹤0.01% 1174
2020
Q1 		$16K Sell
10,640
-50,800
-83% -$2.71M ﹤0.01% 959
2019
Q4 		$318K Buy
61,440
+14,800
+32% +$823K 0.02% 383
2019
Q3 		$106K Buy
46,640
+37,440
+407% +$1.93M 0.01% 600
2019
Q2 		$14K Sell
9,200
-1,120
-11% -$56.2K ﹤0.01% 932
2019
Q1 		$14K Sell
10,320
-720
-7% -$36K ﹤0.01% 885
2018
Q4 		$9K Sell
11,040
-800
-7% -$39.4K ﹤0.01% 961
2018
Q3 		$24K Sell
11,840
-12,160
-51% -$618K ﹤0.01% 733
2018
Q2 		$51K Sell
24,000
-2,480
-9% -$125K ﹤0.01% 676
2018
Q1 		$56K Buy
+26,480
New +$1.23M ﹤0.01% 622
2017
Q1 		– Sell
-24,000
Closed -$5K – 1136
2016
Q4 		$5K Buy
24,000
+4,000
+20% +$198K ﹤0.01% 892
2016
Q3 		$10K Sell
20,000
-11,360
-36% -$623K ﹤0.01% 977
2016
Q2 		$39K Buy
31,360
+19,680
+168% +$1.04M ﹤0.01% 638
2016
Q1 		$3K Sell
11,680
-16,880
-59% -$841K ﹤0.01% 732
2015
Q4 		$7K Buy
28,560
+16,000
+127% +$816K ﹤0.01% 816
2015
Q3 		$6K Sell
12,560
-200,160
-94% -$10.4M ﹤0.01% 933
2015
Q2 		$35K Buy
212,720
+320
+0.2% +$18K ﹤0.01% 717
2015
Q1 		$81K Buy
+212,400
New +$12.2M 0.01% 562

Other funds holding GSK

Dodge & Cox
Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
JEST
JTC Employer Solutions Trustee St Helier, Jersey $1.2B AUM 37.55% 1-Year Est. Return
Fisher Asset Management
Fisher Asset Management Camas, Washington $295B AUM 31.6% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Arrowstreet Capital
Arrowstreet Capital Boston, Massachusetts $185B AUM 39.58% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

HAP Trading's GSK Position: Q1 2023 in Review

HAP Trading sold out of GSK (GSK) in Q1 2023, closing a stake of 33,080 shares — an estimated $1.16M sold.

HAP Trading first reported a position in GSK in Q2 2013 and held it in 15 quarters. The position peaked at $4.42M in Q4 2015. 809 funds tracked by Wall St. Rank hold GSK as of Q1 2023.

  • HAP Trading reported no remaining GSK position as of Q1 2023 after selling out during the quarter.
  • HAP Trading sold 33,080 GSK shares in Q1 2023, an estimated $1.16M.
  • HAP Trading first reported a position in GSK in Q2 2013 and held it in 15 quarters.
  • HAP Trading's GSK position peaked at $4.42M in Q4 2015.
  • 809 funds tracked by Wall St. Rank held GSK as of Q1 2023.

Based on HAP Trading's 13F filing for Q1 2023, filed 12 May 2023.